- Tytuł:
- Crizotinib acts as ABL1 inhibitor combining ATP-binding with allosteric inhibition and is active against native BCR-ABL1 and its resistance and compound mutants BCR-ABL1
- Autorzy:
- Źródło:
- Annals of Hematology. 100(8):2023-2029
Czasopismo naukowe